Q1 2026 Nyxoah SA Earnings Call Transcript

May 12, 2026 / 08:30 PM GMT

Release Date Price: €2.58 (-2.28%)

Transcript

Key Points

Positve

Nyxoah SA (NYXH) achieved a 25% sequential U.S. revenue growth in Q1 2026 compared to Q4 2025, indicating strong execution of their U.S. launch.
The company trained 62 new surgeons in Q1, bringing the total to 207 surgeons trained on the GENIOS system, enhancing their market presence.
Nyxoah SA (NYXH) maintained a 100% approval rate on reviewed prior authorization submissions, showcasing effective market access strategies.
The company expanded its U.S. commercial field presence with 15 additional sales reps, enabling coverage of up to 200 high-volume accounts.
International revenue remained consistent with Q4 2025, avoiding the typical sequential decline, and showing strong performance in markets like Germany and the Middle East.

Negative

Gross margin decreased to 57% in Q1 2026 from 62% in Q1 2025 due to production yield issues, which have been addressed.
Operating expenses increased to EUR 24.2 million in Q1 2026 from EUR 21.4 million in Q1 2025, driven by investments in the U.S. commercial organization.
The company faces ongoing challenges with Medicare, which only represents approximately 10% of their cases, due to initial coding uncertainties.
Despite the growth, Nyxoah SA (NYXH) is still not at break-even, with a revenue target of EUR 150 million needed to achieve this.
The company anticipates a slight gross margin impact in Q2 2026 due to units built in Q1 running through the P&L, delaying full margin recovery.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

NYXH.BR - Nyxoah SA
Q1 2026 Nyxoah SA Earnings Call
May 12, 2026 / 08:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good day, and thank you for standing by. Welcome to the NCSOA First Quarter 2026 Earnings Conference Call. At this time, all participants are in a listen-only mode.

After the speaker's presentation, there'll be a question-and-answer session.

To ask a question during the session, you'll need to press *11 on your telephone.

You will then hear an automated message advising your hand is raised.

To withdraw your question, please press *11 again.

Please be advised that today's conference is being recorded. I'd now like to turn the conference over to your speaker today, Pearson Dennis. Please go ahead.

--------------------------------------------------------------------------------
Unidentified_2 [2]

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.